Company intelligence / Profile preview

xbird

Berlin, Berlin, Germanyxbird.io ↗

Ownership: Private
Development stage: Commercial

Overview

xbird developed an AI-powered digital health platform that uses data from smartphones and wearables to personalize diabetes therapy, predict health risks, and deliver real-time behavioral interventions. Its technology has been integrated into Glooko’s global remote patient monitoring system for diabetes management[1][4][5].

Therapeutic areas: OtherEndocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Diabetes device manufacturersClinical institutions

Beyond the preview

Go deeper on xbird.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xbird.

Explore the full profile